Human Vaccines

Nobilon will start developing its first human vaccines in the multi-purpose facility.

One of the first vaccines to be developed will be a vaccine against Influenza. Influenza vaccines are currently produced on chicken eggs. Now cell culture technology is available which results in efficient and safer vaccines. Nobilon will develop and produce its vaccines based on cell culture technology.

The second group of vaccines under development are traveler vaccines; a vaccine against traveler’s diarrhea is currently being investigated.

Read more about Influenza and traveler's diarrhea